Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019
- Status
- UNKNOWN
- Phase
- NA
Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19
- Status
- UNKNOWN
- Phase
- N/A
A Pilot Study in Severe Patients With Takayasu Arteritis.
- Status
- RECRUITING
- Phase
- PHASE4
Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Tocilizumab REMission in Early RA
- Status
- COMPLETED
- Phase
- PHASE4
A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
- Status
- UNKNOWN
- Phase
- N/A
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease
- Status
- TERMINATED
- Phase
- PHASE1
Treg Modulation With CD28 and IL-6 Receptor Antagonists
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tocilizumab in Children With ACP
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).
- Status
- COMPLETED
- Phase
- PHASE1
Use of Tocilizumab Drug Levels to Optimize Treatment in RA
- Status
- RECRUITING
- Phase
- PHASE4
The Registry Study of Takayasu Arteritis in East China
- Status
- RECRUITING
- Phase
- N/A
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2